Paul Fehlner
Corporate Officer/Principal chez SPYRE THERAPEUTICS, INC.
Fortune : 932 $ au 31/12/2023
Profil
Paul Fehlner is the founder of Life Sciences Innovation LLC, which was founded in 2017.
He held the title of Principal at the firm.
Dr. Fehlner is also the founder of ReVision Therapeutics, Inc. Currently, Dr. Fehlner holds the position of Senior VP & Chief Intellectual Property Counsel at Spyre Therapeutics, Inc. since 2023.
In the past, Dr. Fehlner worked at Darby & Darby as an Associate & Principal.
He also worked at Klauber & Jackson Llc as an Associate.
From 2008 to 2017, he served as the Global Head-Intellectual Property at Novartis Pharma AG.
From 2018 to 2023, he held the positions of Secretary, Chief Legal Officer & Senior VP at Axcella Health, Inc. Dr. Fehlner was also a Partner at Baker Botts LLP from 2006 to 2008.
Regarding education, Dr. Fehlner obtained a graduate degree from Fordham University in 1994.
He completed his undergraduate degree at Haverford College in 1985.
Additionally, he earned a doctorate degree from The Rockefeller University in 1990.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AXCELLA HEALTH, INC.
0,08% | 31/10/2023 | 2 323 ( 0,08% ) | 932 $ | 31/12/2023 |
Postes actifs de Paul Fehlner
| Sociétés | Poste | Début |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 27/11/2023 |
Anciens postes connus de Paul Fehlner
| Sociétés | Poste | Fin |
|---|---|---|
| AXCA HEALPAR | Conseiller Juridique Général | 01/11/2023 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/11/2017 |
Baker Botts LLP
 Baker Botts LLP Miscellaneous Commercial ServicesCommercial Services Baker Botts LLP provides legal services. Its services include antitrust and compensation law, corporate, enforcement and investigations, environmental law, intellectual property, litigation, projects, real estate and construction, regulatory, and tax. The firm renders its services to banking and finance industry, energy and natural resources, manufacturing, and technological industries. The company was founded by Peter Gray in 1840 and is headquartered in Houston, Texas. | Corporate Officer/Principal | 01/01/2008 |
ReVision Therapeutics, Inc.
 ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. The firm operates as a ophthalmic biopharmaceutical company. Its products include Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in April 2010 and is headquartered in La Jolla, CA. | Fondateur | - |
Klauber & Jackson Llc
 Klauber & Jackson Llc Miscellaneous Commercial ServicesCommercial Services Klauber & Jackson Llc is a private company based in Hackensack, NJ. | Corporate Officer/Principal | - |
Formation de Paul Fehlner
| Fordham University | Graduate Degree |
| Haverford College | Undergraduate Degree |
| The Rockefeller University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| AXCA HEALPAR | Health Technology |
| Entreprise privées | 6 |
|---|---|
ReVision Therapeutics, Inc.
ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. The firm operates as a ophthalmic biopharmaceutical company. Its products include Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in April 2010 and is headquartered in La Jolla, CA. | Retail Trade |
Baker Botts LLP
Baker Botts LLP Miscellaneous Commercial ServicesCommercial Services Baker Botts LLP provides legal services. Its services include antitrust and compensation law, corporate, enforcement and investigations, environmental law, intellectual property, litigation, projects, real estate and construction, regulatory, and tax. The firm renders its services to banking and finance industry, energy and natural resources, manufacturing, and technological industries. The company was founded by Peter Gray in 1840 and is headquartered in Houston, Texas. | Commercial Services |
| Darby & Darby | Commercial Services |
Klauber & Jackson Llc
Klauber & Jackson Llc Miscellaneous Commercial ServicesCommercial Services Klauber & Jackson Llc is a private company based in Hackensack, NJ. | Commercial Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| Life Sciences Innovation LLC |
